ArticleEcancermedicalscience2024

Efficacy and safety of trifluridine/tipiracil plus bevacizumab across different subgroups of patients with refractory colorectal cancer: a meta-analysis.

Luís Felipe Leite da Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.